eRaDicate - Innovative ligands for nuclear receptors to eradicate cancer relapse

Project Details

Short titleeRaDicate - Innovative ligands for nuclear receptors to eradicate cancer relapse
StatusActive
Effective start/end date1/01/2431/12/27

Funding

  • UKRI Horizon Europe Underwriting – EPSRC